KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Change in Accured Expenses (2016 - 2025)

Medpace Holdings (MEDP) has disclosed Change in Accured Expenses for 11 consecutive years, with $39.6 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Accured Expenses rose 1241.54% year-over-year to $39.6 million, compared with a TTM value of $97.1 million through Dec 2025, up 475.07%, and an annual FY2025 reading of $97.1 million, up 475.07% over the prior year.
  • Change in Accured Expenses was $39.6 million for Q4 2025 at Medpace Holdings, down from $45.3 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $45.3 million in Q3 2025 and bottomed at -$23.2 million in Q1 2025.
  • Average Change in Accured Expenses over 5 years is $13.7 million, with a median of $16.2 million recorded in 2022.
  • The sharpest move saw Change in Accured Expenses crashed 471.6% in 2021, then soared 1241.54% in 2025.
  • Year by year, Change in Accured Expenses stood at $1.5 million in 2021, then soared by 215.9% to $4.6 million in 2022, then surged by 486.8% to $27.2 million in 2023, then crashed by 89.14% to $2.9 million in 2024, then skyrocketed by 1241.54% to $39.6 million in 2025.
  • Business Quant data shows Change in Accured Expenses for MEDP at $39.6 million in Q4 2025, $45.3 million in Q3 2025, and $35.4 million in Q2 2025.